Janney Montgomery Scott LLC lifted its position in Core Laboratories N.V. (NYSE:CLB) by 75.7% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 20,520 shares of the oil and gas company’s stock after buying an additional 8,844 shares during the period. Janney Montgomery Scott LLC’s holdings in Core Laboratories were worth $2,025,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of CLB. Parallel Advisors LLC grew its holdings in shares of Core Laboratories by 13.1% in the 2nd quarter. Parallel Advisors LLC now owns 1,008 shares of the oil and gas company’s stock worth $101,000 after acquiring an additional 117 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Core Laboratories by 63.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock worth $114,000 after acquiring an additional 439 shares during the last quarter. Advisory Services Network LLC grew its holdings in shares of Core Laboratories by 33.3% in the 2nd quarter. Advisory Services Network LLC now owns 1,365 shares of the oil and gas company’s stock worth $138,000 after acquiring an additional 341 shares during the last quarter. Toronto Dominion Bank grew its holdings in shares of Core Laboratories by 243.6% in the 3rd quarter. Toronto Dominion Bank now owns 1,866 shares of the oil and gas company’s stock worth $184,000 after acquiring an additional 1,323 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership acquired a new position in shares of Core Laboratories in the 2nd quarter worth $203,000.

Core Laboratories N.V. (NYSE CLB) opened at $98.09 on Monday. The company has a debt-to-equity ratio of 1.53, a current ratio of 2.18 and a quick ratio of 1.81. Core Laboratories N.V. has a 52 week low of $86.55 and a 52 week high of $125.83. The company has a market capitalization of $4,330.38, a PE ratio of 53.60 and a beta of 1.56.

Core Laboratories (NYSE:CLB) last issued its earnings results on Monday, October 23rd. The oil and gas company reported $0.48 EPS for the quarter, beating analysts’ consensus estimates of $0.44 by $0.04. Core Laboratories had a return on equity of 52.89% and a net margin of 12.06%. The firm had revenue of $166.20 million for the quarter, compared to the consensus estimate of $160.94 million. During the same quarter in the previous year, the company posted $0.38 earnings per share. The business’s quarterly revenue was up 1.4% compared to the same quarter last year. equities research analysts forecast that Core Laboratories N.V. will post 1.99 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 21st. Shareholders of record on Friday, October 20th were paid a $0.55 dividend. The ex-dividend date was Thursday, October 19th. This represents a $2.20 dividend on an annualized basis and a yield of 2.24%. Core Laboratories’s dividend payout ratio (DPR) is currently 126.44%.

A number of research analysts have recently weighed in on the company. Zacks Investment Research downgraded Core Laboratories from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. Cowen set a $100.00 price target on Core Laboratories and gave the company a “hold” rating in a report on Friday, October 6th. Piper Jaffray Companies set a $97.00 price target on Core Laboratories and gave the company a “hold” rating in a report on Monday, October 23rd. Royal Bank of Canada reiterated a “buy” rating on shares of Core Laboratories in a report on Wednesday, October 18th. Finally, Loop Capital set a $115.00 price target on Core Laboratories and gave the company a “buy” rating in a report on Thursday, December 7th. Three analysts have rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the company. Core Laboratories currently has a consensus rating of “Hold” and an average target price of $110.40.

WARNING: This news story was posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/janney-montgomery-scott-llc-boosts-stake-in-core-laboratories-n-v-clb/1771216.html.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Want to see what other hedge funds are holding CLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Core Laboratories N.V. (NYSE:CLB).

Institutional Ownership by Quarter for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.